多瓣膜原生瓣膜心脏病:EURObservational VHD II 子研究解读
该研究基于 EURObservational VHD II 调查中 5087 例至少 1 个重度左侧原生瓣膜病患者,按瓣膜受累情况分为单瓣膜病组、一个重度伴对侧中度组和≥2 个重度组。结果显示多瓣膜病占近 30%,患者合并心衰和合并症更多、心脏损伤更重,6 个月生存更差且手术率更低。
要点
- 多瓣膜病在左侧原生瓣膜病患者中占近 30%。
- 多瓣膜病患者合并心衰和合并症更多、心脏损伤更重。
- 多瓣膜病 6 个月生存更差且接受瓣膜干预比例更低。
核心结论
- 多瓣膜病在左侧原生瓣膜病患者中常见,约占近 30%,与更重的心脏损伤相关,并导致 6 个月死亡率和心衰发生率高于单瓣膜病,但手术率更低。
研究设计与样本
- EURObservational VHD II 调查纳入 5087 例至少 1 个重度左侧原生瓣膜病患者,每中心最长 3 个月招募期(2017 年 1 月至 8 月),随访 6 个月。
- 患者分为 A 组单左侧瓣膜病 3571 例(70.2%)、B 组一个重度左侧瓣膜病伴同侧另一瓣膜中度病变 363 例(7.1%)、C 组至少 2 个重度原生瓣膜病(左侧和/或三尖瓣反流)1153 例(22.7%)。
主要发现
- 多瓣膜病组(B 和 C 组)较 A 组更多为女性,充血性心衰和合并症更多,左房容积和肺动脉压更高,射血分数更低(所有 P ≤ 0.01)。
- 住院期间 A 组 36.7%(n=1312)、B 组 26.7%(n=97)、C 组 32.7%(n=377)接受瓣膜干预(P < 0.001)。
- 6 个月生存 A 组优于 B 组或 C 组(均 P < 0.001),校正年龄、性别、体重指数和 Charlson 指数后,B 组 HR 1.62(95%CI 1.10-2.38)、C 组 HR 1.72(95%CI 1.32-2.25)均劣于 A 组。
- B 组和 C 组 6 个月时心衰多于 A 组(均 P < 0.001)。
- C 组中与死亡率相关的因素为年龄、心衰和合并症(均 P < 0.010)。
临床怎么用
- 对左侧原生瓣膜病患者应评估是否合并多瓣膜病变,多瓣膜病提示心脏损伤更重且预后更差。
- 多瓣膜病患者合并心衰和合并症较多,6 个月死亡和心衰风险更高,而接受瓣膜干预的比例反而更低,需关注干预决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To assess the characteristics, management, and survival of patients with multiple native valvular heart disease (VHD). METHODS AND RESULTS: Among the 5087 patients with ≥1 severe left-sided native VHD included in the EURObservational VHD II Survey (maximum 3-month recruitment period per centre between January and August 2017 with a 6-month follow-up), 3571 had a single left-sided VHD (Group A, 70.2%), 363 had one severe left-sided VHD with moderate VHD of the other ipsilateral valve (Group B, 7.1%), and 1153 patients (22.7%) had ≥2 severe native VHDs (left-sided and/or tricuspid regurgitation, Group C). Patients with multiple VHD (Groups B and C) were more often women, had greater congestive heart failure (CHF) and comorbidity, higher left atrial volumes and pulmonary pressures, and lower ejection fraction than Group A patients (all P ≤ 0.01). During the index hospitalization, 36.7% of Group A (n = 1312), 26.7% of Group B (n = 97), and 32.7% of Group C (n = 377) underwent valvular intervention (P < 0.001). Six-month survival was better for Group A than for Group B or C (both P < 0.001), even after adjustment for age, sex, body mass index, and Charlson index [hazard ratio (HR) 95% confidence interval (CI) 1.62 (1.10-2.38) vs. Group B and HR 95% CI 1.72 (1.32-2.25) vs. Group C]. Groups B and C had more CHF at 6 months than Group A (both P < 0.001). Factors associated with mortality in Group C were age, CHF, and comorbidity (all P < 0.010). CONCLUSION: Multiple VHD is common, encountered in nearly 30% of patients with left-sided native VHD, and associated with greater cardiac damage and leads to higher mortality and more heart failure at 6 months than single VHD, yet with lower rates of surgery.
引用
- Tribouilloy C, Bohbot Y, Kubala M, et al. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey. Eur Heart J. 2022. PMID: 35511056. doi:10.1093/eurheartj/ehac209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。